Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01TMQ
|
||||
Former ID |
DCL000733
|
||||
Drug Name |
Bupropion+naltrexone
|
||||
Synonyms |
Contrave (TN)
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Obesity [ICD9: 278; ICD10:E66] | Phase 3 | [532233] | ||
Company |
Orexigen Therapeutics
|
||||
Structure |
Download2D MOL |
||||
Formula |
C13H18ClNO
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Dopamine reuptake | Target Info | Inhibitor | [536710] | |
Sodium-dependent noradrenaline transporter | Target Info | Inhibitor | [536710] | ||
Opioid receptor | Target Info | Antagonist | [536710] | ||
PANTHER Pathway | Adrenaline and noradrenaline biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.